Intravenous (IV) Hydration Therapy Market Size, Share, Report 2023-2032
The global intravenous (IV) hydration therapy market was estimated at USD 2.35 billion in 2022 and it is expected to surpass around USD 5.07 billion by 2032, poised to grow at a CAGR of 7.99% from 2023 to 2032. The intravenous (IV) hydration therapy market in the United States was accounted for USD 0.97 billion in 2022.
Key Pointers
Report Scope of the Intravenous (IV) Hydration Therapy Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 47% |
| Revenue Forecast by 2032 | USD 5.07 billion |
| Growth Rate from 2023 to 2032 | CAGR of 7.99% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Core IV Therapy, LLC; Cryojuvenate UK Ltd.; B. Braun Medical Inc.; Otsuka Pharmaceutical Co., Ltd.; NexGen Health; JW Life Science Corporation; Amanta Healthcare; Baxter International Inc.; Drip Hydration |
The growth of the market is attributed to therising prevalence of chronic diseases, the growing popularity of wellness and beauty treatments, and the increasing availability of IV hydration therapy clinics, as well as the ease of use associated with this therapy. The procedure has gained immense popularity in recent times, owing to the advantages associated with it, and the use of the therapy in a wide array of applications.
A team of academics led by scientists from the Washington University School of Medicine announced new discoveries in August 2020. According to their findings, people became ill when infected with COVID-19 because their immune systems do not provide the essential amount of protection to prevent significant symptoms. As per these specialists, boosting the immune system could be an effective COVID-19 treatment. This is when IV hydration therapy came into the limelight as a method to boost an individual’s immune system, thus driving its demand during the pandemic.
Furthermore, IV hydration therapy has gained immense popularity in the cosmetic industry, owing to the skincare benefits offered by the procedure. It has been found through extensive research that the therapy helps in providing beauty treatment by hydrating the skin, further enhancing the appearance of an individual. IV hydration therapy is believed to enhance the normal production of elastin and collagen, which are responsible for maintaining youthful and healthy-looking skin. This can help to reduce the appearance of wrinkles and fine lines over time.
Moreover, technological advancements in the healthcare industry aided by the benefits of IV hydration therapy, including better convenience, cost-effectiveness, better outcomes, and higher safety standards, are further fueling the growth of the market. The growing geriatric population that is affected by chronic conditions requiring infusion therapies is increasing their demand and use. Moreover, efforts are being taken by key players while taking into consideration consumer demands, to provide effective and enhanced results and help in the better adoption of the technology globally.
However, IV hydration therapy, despite displaying several benefits for the physical and overall wellness of an individual, faces a major setback to its growth, which is that none of the therapies are approved by the FDA, signifying that the benefits associated with them are not clinically validated.
Service Insights
Based on service, the energy boosters segment held the largest market share of 27% in 2022. The dominance of the segment is attributed to the increasing popularity of these therapies in providing rapid and effective energy requirements. Energy IV therapy contains antioxidants, amino acids, and nutrients that aid in increasing energy levels, as well as improving mental clarity, mood, and focus. They tend to provide a boost in energy naturally and safely without incorporating stimulants or drugs, which is expected to drive the demand.
However, the skin care segment is expected to expand at the fastest growth rate over the forecast period. The growth can be attributed to the increasing patient spending on cosmetic procedures and beautification. Beauty IV drips are made up of a special combination of minerals, electrolytes, and vitamins that help them to target and remove free radicals that lead to aging. Additionally, they cleanse the body naturally and remove toxins to give a youthful appearance to the skin. All these beauty benefits offered by the products have resulted in the growing demand for skin care services.
Component Insights
Based on the component, the medicated segment held the largest revenue share of 68% in the IV hydration therapy market in 2022. This dominance is attributed to the growing demand for medications to be provided to patients through the IV route, along with key players focusing on developing customizable medicated IV hydration therapy solutions.
For instance, Drip Hydration offers Stomach Flu IV treatment, which comprises an infusion of a blend of electrolytes, vitamins, fluids, and drugs to heal stomach flu symptoms and restore hydration of the body within 30-60 minutes. This IV medication contains Vitamin B12, B-Complex vitamins, Vitamin C, Zofran, and Pepcid. Zofran is an anti-nausea/vomiting medication that helps to reduce nausea and vomiting caused by stomach flu.
On the other hand, the non-medicated segment is expected to grow at the fastest rate over the forecast period. The segment advancement can be attributed to the rising demand for therapies in beauty- and energy-boosting applications. The constantly growing global population is widely adopting IV hydration therapy for hydrating their skin to retain its natural glow.
End-use Insights
Based on end-use, hospitals & clinics held the dominant market share of 43% in 2022. The segment growth can be attributed to the rising need for hospitalization due to an increase in the number of people suffering from chronic disorders. On average, hospitalizations may last for 4-5 days, driving the need for supplying medications and nutrients to patients through IV routes. Moreover, these services are offered in hospitals at a lower cost under the supervision of a licensed physician, making it a prime location for IV hydration therapy, thus driving market growth.
However, the home healthcare segment is expected to witness the fastest growth over the forecast period. The growth of the segment is due to the rapidly increasing geriatric population that is prone to various disorders. Moreover, the emergence of the COVID-19 pandemic, which highlighted the necessity for medical equipment, particularly in a home-based scenario where the virus is transmitted through physical contact, resulted in the higher adoption of homecare services.
Regional Insights
North America dominated the market for IV hydration therapy with a share of 47% in 2022 and is anticipated to maintain its dominance over the forecast period. The high share of the regional market is due to the unprecedented adoption of IV hydration therapy in the U.S. There is an increasing demand for energy and immune boosters in the region, owing to rising incidences of chronic diseases.
The region boasts a high disposable income and high patient spending on overall wellness, which increases the adoption of the market. Moreover, key players in the region are constantly focusing on introducing newer technologies into the market to meet the changing consumer demands, which is further anticipated to drive regional market growth. For instance, in December 2022, The DRIPBaR entered a partnership with entrepreneur and investor Kevin Harrington, who will be a major investor in the IV therapy franchise. The franchise has been gaining immense acceptance across the region.
On the other hand, Asia Pacific is estimated to be the fastest-growing region over the forecast period. The region's expansion can be attributable to the increased awareness of IV hydration therapy and its associated benefits. Moreover, the market is expected to witness a surge in demand owing to initiatives being taken by healthcare facilities in the region, as a result of the rising occurrence of various immunity disorders. For instance, in December 2022, Chinese clinics announced the launch of a drive-through IV Infusion system to help deal with the overwhelming number of COVID patients.
Intravenous (IV) Hydration Therapy Market Segmentations:
By Service
By Component
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Service Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Intravenous (IV) Hydration Therapy Market
5.1. COVID-19 Landscape: Intravenous (IV) Hydration Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Intravenous (IV) Hydration Therapy Market, By Service
8.1. Intravenous (IV) Hydration Therapy Market, by Service, 2023-2032
8.1.1 Immune Boosters
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Energy Boosters
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Skin Care
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Migraine
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Intravenous (IV) Hydration Therapy Market, By Component
9.1. Intravenous (IV) Hydration Therapy Market, by Component, 2023-2032
9.1.1. Medicated
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Non-medicated
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Intravenous (IV) Hydration Therapy Market, By End-use
10.1. Intravenous (IV) Hydration Therapy Market, by End-use, 2023-2032
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Wellness Centers & Spas
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Intravenous (IV) Hydration Therapy Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2020-2032)
11.1.2. Market Revenue and Forecast, by Component (2020-2032)
11.1.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2020-2032)
11.2.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2020-2032)
11.3.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2020-2032)
11.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2020-2032)
11.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 12. Company Profiles
12.1. Core IV Therapy, LLC
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cryojuvenate UK Ltd.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. B. Braun Medical Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Otsuka Pharmaceutical Co., Ltd..
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. NexGen Health
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. JW Life Science Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Amanta Healthcare.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Baxter International Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Drip Hydration.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers